387 related articles for article (PubMed ID: 15742443)
1. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
Gonzalez-Gay MA; Rubiera G; Piñeiro A; Garcia-Porrua C; Pego-Reigosa R; Gonzalez-Juanatey C; Sanchez-Andrade A; Llorca J
J Rheumatol; 2005 Mar; 32(3):502-6. PubMed ID: 15742443
[TBL] [Abstract][Full Text] [Related]
2. Cancer in biopsy-proven giant cell arteritis. A population-based study.
Gonzalez-Gay MA; Lopez-Diaz MJ; Martinez-Lado L; Peña-Sagredo JL; Lopez-Agreda H; Miranda-Filloy JA; Gonzalez-Juanatey C; Sanchez-Andrade A; Martin J; Llorca J
Semin Arthritis Rheum; 2007 Dec; 37(3):156-63. PubMed ID: 17509668
[TBL] [Abstract][Full Text] [Related]
3. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Aug; 51(4):652-5. PubMed ID: 15334440
[TBL] [Abstract][Full Text] [Related]
4. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality.
González-Gay MA; Blanco R; Abraira V; García-Porrúa C; Ibáñez D; García-Pais MJ; Rigueiro MT; Sánchez-Andrade A; Guerrero J; Casariego E
J Rheumatol; 1997 Nov; 24(11):2171-6. PubMed ID: 9375880
[TBL] [Abstract][Full Text] [Related]
5. Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
J Rheumatol; 2003 Jul; 30(7):1548-51. PubMed ID: 12858456
[TBL] [Abstract][Full Text] [Related]
6. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features.
González-Gay MA; Blanco R; Sánchez-Andrade A; Vázquez-Caruncho M
J Rheumatol; 1997 Nov; 24(11):2166-70. PubMed ID: 9375879
[TBL] [Abstract][Full Text] [Related]
7. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.
Gonzalez-Gay MA; Garcia-Porrua C; Llorca J; Gonzalez-Louzao C; Rodriguez-Ledo P
Semin Arthritis Rheum; 2001 Feb; 30(4):249-56. PubMed ID: 11182025
[TBL] [Abstract][Full Text] [Related]
8. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.
Ninan J; Nguyen AM; Cole A; Rischmueller M; Dodd T; Roberts-Thomson P; Hill CL
J Rheumatol; 2011 Oct; 38(10):2215-7. PubMed ID: 21844141
[TBL] [Abstract][Full Text] [Related]
9. Giant cell arteritis without clinically evident vascular involvement in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Apr; 51(2):274-7. PubMed ID: 15077272
[TBL] [Abstract][Full Text] [Related]
10. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
Uddhammar A; Eriksson AL; Nyström L; Stenling R; Rantapää-Dahlqvist S
J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015
[TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
13. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
[TBL] [Abstract][Full Text] [Related]
15. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
16. Analysis of temporal artery biopsies in an 18-year period at a community hospital.
Marí B; Monteagudo M; Bustamante E; Pérez J; Casanovas A; Jordana R; Tolosa C; Oristrell J
Eur J Intern Med; 2009 Sep; 20(5):533-6. PubMed ID: 19712860
[TBL] [Abstract][Full Text] [Related]
17. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
[TBL] [Abstract][Full Text] [Related]
20. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
